Literature DB >> 3702918

Progress against cancer?

J C Bailar, E M Smith.   

Abstract

We assessed the overall progress against cancer during the years 1950 to 1982. In the United States, these years were associated with increases in the number of deaths from cancer, in the crude cancer-related mortality rate, in the age-adjusted mortality rate, and in both the crude and the age-adjusted incidence rates, whereas reported survival rates (crude and relative) for cancer patients also increased. In our view, the best single measure of progress against cancer is change in the age-adjusted mortality rate associated with all cancers combined in the total population. According to this measure, we are losing the war against cancer, notwithstanding progress against several uncommon forms of the disease, improvements in palliation, and extension of the productive years of life. A shift in research emphasis, from research on treatment to research on prevention, seems necessary if substantial progress against cancer is to be forthcoming.

Entities:  

Mesh:

Year:  1986        PMID: 3702918     DOI: 10.1056/NEJM198605083141905

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  56 in total

Review 1.  Nutritional intervention studies in cancer prevention.

Authors:  L E Holm
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

2.  Progress against cancer (1971-2011): how far have we come?

Authors:  A K Tiwari; H K Roy
Journal:  J Intern Med       Date:  2011-10-20       Impact factor: 8.989

3.  Comment on "the predictive capacity of personal genome sequencing".

Authors:  Colin B Begg; Malcolm C Pike
Journal:  Sci Transl Med       Date:  2012-05-23       Impact factor: 17.956

4.  The aging process: major risk factor for disease and death.

Authors:  D Harman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

5.  Tobacco smoke load and non-lung cancer mortality associations in Austrian and German males.

Authors:  Livia Borsoi; Bruce Leistikow; Manfred Neuberger
Journal:  Wien Klin Wochenschr       Date:  2010-11-15       Impact factor: 1.704

6.  Trends in cancer incidence, survival and mortality in northern Sweden 1960-1986.

Authors:  P Lenner; H Jonsson; O Gardfjell
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

7.  Why is preventive medicine exempted from ethical constraints?

Authors:  P Skrabanek
Journal:  J Med Ethics       Date:  1990-12       Impact factor: 2.903

8.  Science versus quackery.

Authors:  E Baldwin
Journal:  J R Soc Med       Date:  1996-12       Impact factor: 5.344

9.  Firm measures are required to effect any significant decrease in the Japanese age-adjusted mortality rate from malignant neoplasms for the 21st century.

Authors:  Shigeyuki Nakaji; Qiang Liu; Tatsuya Yamamoto; Yukika Kakuta; Juichi Sakamoto; Kazuo Sugawara; John C Bailar
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

10.  Generational risks for cancers not related to tobacco, screening, or treatment in the United States.

Authors:  Yueh-Ying Han; Devra L Davis; Joel L Weissfeld; Gregg E Dinse
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.